ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,329, issued on Nov. 18, was assigned to Amgen Inc. (Thousand Oaks, Calif.).
"Methods directed to crystalline biomolecules" was invented by Rizwan Sharnez (Mead, Colo.), William Trieu (Agoura Hills, Calif.), Marc A. Caporini (Cambridge, Mass.), Ron C. Kelly (Thousand Oaks, Calif.), Neill Burt (Denver), Laura Nicholson (Boulder, Colo.) and Twinkle R. Christian (Thousand Oaks, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods of preparing a composition comprising crystalline biomolecules, for example, crystalline antibodies. In exemplary embodiments, the method comprises forming a fluidized bed of crystalline biomolecul...